HealthU.S. FDA approves Lilly’s Mounjaro to reduce cardiovascular risk
Eli Lilly said the U.S. FDA has approved Mounjaro, its diabetes drug, to lower the risk of heart attack or stroke among adults with type 2 diabetes who face a high risk of cardiovascular events.
R
Reuters★★★☆☆2026-08-28 12:40Original
U.S. FDA approves Lilly’s Mounjaro to reduce cardiovascular risk
Health